Mounjaro for Diabetics: What It Does and Who Can Take It (October 2026)

01

Is Mounjaro for diabetics, and what does it do?

Mounjaro is for diabetics, but it is also for people without diabetes who need weight management. In the UK it is licensed for weight management in adults and for type 2 diabetes. It is a once-weekly injectable prescription medicine made by Eli Lilly, supplied as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

In plain terms, it does two jobs at once. It helps the body handle sugar, and it helps reduce appetite so that eating less becomes more manageable.

The mechanism is what sets it apart. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

02

The decisions you are actually facing

Each leads to a different next step.

• You have diabetes and want to know whether Mounjaro is an option. This is a conversation for your GP or diabetes team. They hold your blood sugar results, your current medicines and your history. Our page on whether diabetics can take Mounjaro covers the practical questions to bring.
• You have diabetes and mainly want to lose weight. The medicine supports weight loss alongside a reduced-calorie diet and increased physical activity, but your diabetes care should stay coordinated. See how weight loss works for people with diabetes.
• You do not have diabetes and wonder if Mounjaro is meant for you. It can be, because weight management is a licensed use. Our page on whether the medicine is only for people with diabetes answers that directly.

Whatever your situation, the same principle applies. The medicine is prescription-only and is supplied only after a consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity, and individual results vary.¹

03

Why your diabetes team should know

If you have diabetes, treatment and monitoring are coordinated differently, so tell your prescriber and your usual diabetes team so care stays joined up.¹ That sentence matters more than it looks. A medicine that changes how your body handles sugar can change how your other diabetes medicines behave.

Practically, that means keeping your routine appointments, bringing a list of everything you take, and telling each clinician about any new medicine you start. It also means not changing any diabetes medicine by yourself. If you are on insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar, and that adjustment is for your clinician to make, not something to guess at.¹

If you are ready to look at private treatment as a weight-management option, the Mounjaro pen page shows current doses and prices. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). Doses are in stock across the range. For the wider picture, see our weight loss clinic.

One caution: do not start any treatment to replace advice from the people managing your diabetes. A consultation with us is for assessing suitability, and you should be open about your diagnosis and medicines so the prescriber can judge safely.

Related guides: How does mounjaro work for diabetics and Is mounjaro for diabetics only and Can diabetics lose weight on mounjaro and Is mounjaro good for diabetics.

04 · How it works

How Mounjaro works in the body

Mounjaro works by activating two natural gut-hormone receptors at once. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

It helps to unpack each effect, because they explain why the medicine suits both diabetes and weight management.

Appetite. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ This matters for anyone with diabetes who has struggled to eat less despite real effort. The medicine does not remove the need for a sensible diet. It makes following one less of a daily battle for many people.

Stomach emptying. Food leaves the stomach more slowly, which contributes to feeling full for longer. It is also the reason the medicine can affect how oral tablets are absorbed, including oral contraceptive pills.

Insulin response. The medicine improves the way the body responds to insulin. For a person with diabetes this is the heart of the blood sugar benefit. It is why the licence covers both HbA1c control and weight loss, rather than weight alone.

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ That does not mean one is right for everyone. It means the two work differently, and a prescriber chooses between them on your circumstances, not on a slogan.

Many readers ask how this plays out day to day if they already have a diabetes diagnosis. Our dedicated page on how Mounjaro works for diabetics goes further on that question.

It is also worth being clear about what the medicine does not do. It is not a one-off cure and it does not replace your diet, activity or routine diabetes care. The pen is injected once a week, and the effect depends on continuing treatment as your prescriber advises. Because it is a weekly rather than daily medicine, many people find the routine easier to keep, but the dose is stepped up gradually and reviewed along the way.

How strongly you feel the appetite effect, and how your blood sugar responds, differs from person to person. That is exactly why monitoring by a clinician matters from the first dose onward.

05 · Diabetes licence

What the diabetes licence means

Mounjaro is licensed in the UK for both weight management in adults and for type 2 diabetes, so a diabetes diagnosis is not a requirement for taking it. Mounjaro is also licensed for type 2 diabetes, where it improves blood sugar control (HbA1c) and supports weight loss.¹⁸

This is the answer to the common question of whether Mounjaro is just for diabetics. It started as a diabetes medicine in many people's minds, but the UK licence now covers two separate purposes. The same active ingredient and the same pen are involved, yet the reason for prescribing differs.

When the purpose is diabetes control, the prescriber focuses on blood sugar, HbA1c and your other diabetes medicines. When the purpose is weight management, the focus is on weight, weight-related conditions and the lifestyle plan around the injection. For someone with diabetes who also wants to lose weight, those two aims overlap, and the same medicine may serve both.

That overlap is why clear communication matters. If one clinician prescribes for weight and another manages your diabetes, each needs to know what the other is doing. Our page on whether Mounjaro is good for diabetics looks at the benefits and trade-offs more closely.

A few points are worth stating plainly:

• The licence tells you what the medicine is approved for. It does not tell you whether it is right for you personally.
• Eligibility on the NHS follows separate NICE guidance for each purpose, and local services apply it in phases.
• Private treatment is a prescribing decision made after a consultation, not an automatic entitlement.

If your diagnosis is not the common adult form of diabetes, or you are unsure which type you have, speak to your diabetes team before anything else.

Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive; if you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems, so always share your full medical history and medicine list during consultation. Read the patient information leaflet that comes with the pen before your first dose, and keep it to hand.¹³

06 · Weight results

What trial results say about weight loss

The main published weight-loss figures come from the SURMOUNT-1 trial, and they are averages, not predictions. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² That caveat applies doubly if you have diabetes, because your own response depends on your starting point, your other medicines and how consistently you follow your plan.

The same trial reports how many participants reached particular thresholds. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

As a worked example, for someone starting at 100 kg, 20.9% is about 21 kg. That is straight arithmetic from the trial average, not a forecast for you, and it says nothing about how quickly it would happen.

Two honest cautions follow. First, these SURMOUNT-1 figures are not specific to people with diabetes, so do not assume they describe a group with diabetes. Ask your prescriber what to expect in your situation. Second, a trial average hides a wide spread of experiences, and some people lose less than the average.

If weight loss is your main goal alongside diabetes, our guide on whether diabetics can lose weight on Mounjaro covers expectations in more detail. For readers without diabetes, the safety page for non-diabetics is the better starting point.

The most useful way to think about results is as a partnership between the medicine and your habits. The injection can reduce hunger and make a calorie-reduced diet easier to keep. Gradual changes in eating and activity do the rest, and your prescriber reviews progress along the way.

07 · Medicines and interactions

Other medicines, interactions and what to avoid

If you take other medicines, the safest approach is to give your prescriber a full and honest list before starting Mounjaro.

Two points are clear and worth knowing.

Insulin and sulfonylureas. If you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar. That is an adjustment for your clinician to guide, not a reason the medicines can never be used together. Never reduce or stop a diabetes medicine on your own.

Oral contraceptives. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ Mounjaro can reduce absorption of oral contraceptives because stomach emptying slows. If contraception matters to you, discuss it with your prescriber before you start and when the dose changes, and read the MHRA guidance.⁷

Readers also ask what to avoid while taking the medicine, and what foods ease side effects. If a particular food or meal size makes you feel unwell, tell your prescriber or pharmacist, who can advise on your situation.

The most common side effects of Mounjaro, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Tell your prescriber about any new or lasting symptom; for severe, persistent stomach pain, swelling of the face or throat, or difficulty breathing, get medical help straight away. You can also report suspected side effects through the MHRA Yellow Card scheme.¹⁹

A practical habit helps here: keep one up-to-date medicine list, including anything bought without a prescription, and show it at every appointment, whether with your GP, diabetes nurse, pharmacist or our prescribing team. Our page on side effects in the first week gives a general feel for the early stage, although your own diabetes situation may add considerations that your clinician should address.

08 · NHS or private

Can diabetics get Mounjaro on the NHS, or is it free?

Mounjaro is available on the NHS, but access is being phased in over several years.

NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions). Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁴⁶

That covers weight management. For diabetes treatment, the decision usually sits with your GP or diabetes team, who follow NICE guidance on the medicine for diabetes.⁸ Whether you would be offered it depends on your blood sugar control, your current medicines and local arrangements, so ask them directly rather than relying on a general web answer.

On cost, a prescription in England usually carries the NHS prescription charge of £9.90 per item unless you qualify for an exemption. Ask your pharmacist or GP surgery whether you are exempt. That answers the common question of whether the medicine is free for diabetics: it may be provided through the NHS if your team prescribes it, but it is not automatically free, and the route depends on the prescriber and your eligibility.

If you do not meet the NHS criteria, or you would rather not wait, private treatment is a regulated alternative. The NHS guide to the medicine is a reliable independent read.⁵

Privately, the Mounjaro pen is priced by dose. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price (code DOSE25). Prices checked 11 October 2026.

Private treatment is a purchase decision, so take your time. Compare it with what your NHS team may offer, and tell your diabetes team if you go private so that your records stay accurate.

09 · Staying on treatment

How long can diabetics stay on Mounjaro, and what happens if you stop?

For someone with diabetes, the length of treatment is tied to why it is prescribed. If it is for blood sugar control, your diabetes team will review your results regularly and decide whether it continues to suit you. If it is for weight management, the prescribing team reviews your progress and your dose over time. Our service includes ongoing monthly reviews, dose titration and follow-up assessments by the prescribing team, and repeat orders re-check suitability, with no auto-shipping.

Doses are stepped up gradually. Your prescriber decides based on how you respond and how you tolerate each step. Do not increase a dose by yourself.

Stopping is a decision to make with your clinician, especially if you have diabetes, because your blood sugar management may need to change. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.

Plan for what follows. If you stop, your appetite and your blood sugar may change over the weeks afterwards, so keep your diet and activity routine going and stay in touch with your diabetes team for monitoring.

Finally, think about practicalities that keep treatment safe. Keep unopened pens in the fridge until first use; they keep until the printed expiry date. Once in use, a KwikPen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen. Follow the pen's instructions for injecting and check the leaflet for storage details.¹³

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · Ordering privately

How private ordering works if you decide to go ahead

You only need to follow three steps, and the process is the same whatever your health background.

Step one: the free consultation. You complete a short health questionnaire, with no charge and no obligation. Be completely honest about your diabetes, your medicines and your medical history, because the prescriber relies on what you tell them.

Step two: prescriber review. Your answers are reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. If your situation is complicated by diabetes, the prescriber may take longer or may advise that your diabetes team is better placed to guide you.

Step three: dispensing and delivery. Approved orders are dispensed by our registered pharmacy (GPhC 9012878). Same-day dispatch applies when ordered by 3pm, and delivery is free, next-day, tracked and temperature-controlled in discreet packaging. Saturday delivery is £14.99. Needles, a sharps bin and injection guidance come with every order.

A few points that readers often care about:

• We supply Mounjaro directly through official LillyDirect supply, so you receive genuine KwikPens.
• The consultation is free, the price shown is the price paid, and there are no hidden fees.
• You can pay by Visa or Mastercard or Klarna, and pay-monthly options exist. There are no subscriptions.
• Our free companion app, GLPTrackr, helps you track your journey on iOS and Android.
• Support runs Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat, or by phone on 0333 207 0413.

On cost planning, if you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. A new customer's first order is £40 less, and every later order is £25 less. Individual doses sit between £169.99 at 2.5mg and £329.99 at 15mg per month.

Beware of anyone offering to supply without a consultation or prescription, or at suspiciously low cost. Counterfeit medicines are a real risk, and the MHRA publishes alerts.⁷ You can verify our registration on the GPhC register.¹²

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.